| Followers | 22 |
| Posts | 12999 |
| Boards Moderated | 0 |
| Alias Born | 01/16/2026 |
Monday, April 06, 2026 4:31:25 AM
Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO
April 6, 2026 4:15 AM
PR Newswire (US)
LOS ANGELES, April 6, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Soleno Therapeutics, Inc. ("Soleno" or "the Company") (NASDAQ: SLNO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of SLNO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: March 26, 2025 to November 4, 2025
DEADLINE: May 5, 2026
CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Soleno's Phase 3 clinical trial of diazoxide choline extended-release tablets ("DCCR") revealed safety concerns about the drug candidate, which it subsequently downplayed. DCCR suffered from diminished commercial viability. Based on these facts, Soleno's public statements were false and materially misleading throughout the class period.
If you are a shareholder who suffered a loss, contact us to participate.
WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.
Join the case to recover your losses.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com
View original content:https://www.prnewswire.com/news-releases/soleno-therapeutics-inc-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--slno-302734456.html
SOURCE DJS Law Group LLP
Recent SLNO News
- Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO • PR Newswire (US) • 04/13/2026 07:49:00 AM
- SLNO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Soleno Therapeutics, Inc. Securities Lawsuit -- The Gross Law Firm • PR Newswire (US) • 04/07/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 10:58:45 AM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 04/06/2026 09:17:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/06/2026 11:46:57 AM
- Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio • PR Newswire (US) • 04/06/2026 11:00:00 AM
- Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO • PR Newswire (US) • 04/06/2026 08:15:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 12:17:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 12:15:43 AM
- SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm • PR Newswire (US) • 03/31/2026 01:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 03/27/2026 05:16:59 PM
- SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting DCCR Safety Timeline: SueWallSt • PR Newswire (US) • 03/26/2026 01:00:00 PM
- SLNO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Soleno Therapeutics, Inc. Securities Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/24/2026 01:00:00 PM
- Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO • PR Newswire (US) • 03/23/2026 06:11:00 AM
- Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO • PR Newswire (US) • 03/20/2026 08:07:00 AM
- SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Conducting Sham Clinical Trials: SueWallSt • PR Newswire (US) • 03/19/2026 01:00:00 PM
- SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm • PR Newswire (US) • 03/17/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 01:28:28 PM
- Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO • PR Newswire (US) • 03/16/2026 07:03:00 AM
- SLNO Lawsuit Alleges Allegedly Conducting Sham Clinical Trials - Soleno Therapeutics, Inc. Investors Face Losses Following Allegedly Conducting Sham Clinical Trials: SueWallSt • PR Newswire (US) • 03/12/2026 01:00:00 PM
- Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO • PR Newswire (US) • 03/12/2026 08:40:00 AM
- Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SLNO • Business Wire • 03/10/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:59:56 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:58:24 PM
- Soleno Therapeutics Announces Retirement of James Mackaness and Appointment of Jennifer Fulk as Chief Financial Officer • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
